Dr. Harshmeen Kaur is a highly experienced professional in the field of pharmacovigilance and medical writing, with a career spanning over nine years. Beginning as a Pharmacovigilance Analyst at Quantum Solutions India from February 2014 to April 2015, Dr. Kaur then advanced to the role of Pharmacovigilance Specialist/Medical Writer II at Parexel from May 2015 to July 2020, focusing on the authorship of Safety Evaluation Reports and Periodic Safety Update Reports. Currently, Dr. Kaur serves as a Benefit and Risk Scientist II at Diamond Pharma Services since June 2021 and as a Senior Pharmacovigilance Safety Scientist at ProPharma Group since September 2022. Dr. Kaur holds a Bachelor of Dental Surgery (BDS) degree from Luxmi Bai Institute of Dental Sciences & Hospital, earned between 2006 and 2011, achieving first-grade honors.
This person is not in any teams
This person is not in any offices